Sino Land Co Ltd
HKEX:83
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.51
9.16
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Sino Land Co Ltd
Current Assets | 70.4B |
Cash & Short-Term Investments | 46.4B |
Receivables | 8.2B |
Other Current Assets | 15.8B |
Non-Current Assets | 109.9B |
Long-Term Investments | 90.9B |
PP&E | 2.9B |
Other Non-Current Assets | 16.1B |
Current Liabilities | 7.8B |
Accounts Payable | 4.4B |
Short-Term Debt | 2.5B |
Other Current Liabilities | 970m |
Non-Current Liabilities | 6.7B |
Long-Term Debt | 3.5B |
Other Non-Current Liabilities | 3.3B |
Balance Sheet
Sino Land Co Ltd
Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
3 620
|
3 022
|
3 421
|
11 405
|
6 019
|
3 592
|
3 593
|
2 793
|
1 807
|
|
Cash |
0
|
3 620
|
3 022
|
3 421
|
11 405
|
6 019
|
3 592
|
3 593
|
2 793
|
1 807
|
|
Short-Term Investments |
19 515
|
23 284
|
28 204
|
18 549
|
27 297
|
37 532
|
40 552
|
41 199
|
41 124
|
44 623
|
|
Total Receivables |
3 519
|
3 726
|
2 897
|
3 768
|
7 818
|
5 807
|
7 503
|
6 242
|
7 312
|
8 195
|
|
Accounts Receivables |
2 165
|
1 679
|
205
|
206
|
219
|
249
|
258
|
319
|
276
|
2 010
|
|
Other Receivables |
1 354
|
2 047
|
2 692
|
3 563
|
7 599
|
5 558
|
7 245
|
5 923
|
7 036
|
6 185
|
|
Inventory |
27 638
|
27 092
|
24 877
|
27 053
|
27 620
|
30 912
|
23 162
|
20 390
|
16 390
|
15 810
|
|
Other Current Assets |
532
|
566
|
1 946
|
454
|
404
|
122
|
0
|
0
|
24
|
0
|
|
Total Current Assets |
51 204
|
58 287
|
60 947
|
53 244
|
74 544
|
80 391
|
74 808
|
71 425
|
67 643
|
70 435
|
|
PP&E Net |
1 835
|
2 143
|
2 136
|
2 153
|
2 112
|
3 091
|
3 121
|
2 959
|
2 999
|
2 904
|
|
PP&E Gross |
1 835
|
2 143
|
2 136
|
2 153
|
2 112
|
3 091
|
3 121
|
2 959
|
2 999
|
0
|
|
Accumulated Depreciation |
652
|
726
|
803
|
893
|
1 006
|
1 071
|
1 203
|
1 276
|
1 399
|
0
|
|
Note Receivable |
9 573
|
8 073
|
8 994
|
15 544
|
11 803
|
16 171
|
17 036
|
18 073
|
17 867
|
16 123
|
|
Long-Term Investments |
78 014
|
79 390
|
82 062
|
87 048
|
91 185
|
87 069
|
86 749
|
86 522
|
90 754
|
90 872
|
|
Other Long-Term Assets |
1 178
|
1 165
|
1 126
|
1 118
|
1 104
|
0
|
0
|
5
|
8
|
10
|
|
Total Assets |
141 803
N/A
|
149 058
+5%
|
155 266
+4%
|
159 107
+2%
|
180 748
+14%
|
186 724
+3%
|
181 715
-3%
|
178 984
-2%
|
179 271
+0%
|
180 344
+1%
|
|
Liabilities | |||||||||||
Accounts Payable |
8 178
|
5 765
|
4 535
|
5 944
|
4 967
|
4 974
|
5 120
|
5 335
|
5 059
|
4 391
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1 813
|
1 748
|
2 499
|
2 457
|
|
Current Portion of Long-Term Debt |
801
|
0
|
3 875
|
720
|
0
|
864
|
2 894
|
2 285
|
1 174
|
20
|
|
Other Current Liabilities |
3 863
|
11 884
|
11 640
|
5 468
|
20 418
|
26 481
|
8 138
|
5 737
|
2 171
|
950
|
|
Total Current Liabilities |
12 843
|
17 650
|
20 051
|
12 131
|
25 386
|
32 319
|
17 966
|
15 105
|
10 902
|
7 818
|
|
Long-Term Debt |
5 238
|
4 442
|
2 056
|
1 667
|
5 062
|
4 497
|
4 206
|
2 957
|
2 580
|
3 453
|
|
Deferred Income Tax |
2 030
|
1 926
|
2 161
|
2 387
|
2 445
|
2 488
|
2 647
|
2 694
|
2 684
|
2 757
|
|
Minority Interest |
468
|
543
|
971
|
860
|
868
|
843
|
1 649
|
831
|
756
|
526
|
|
Other Liabilities |
2 667
|
2 366
|
1 673
|
2 480
|
1 693
|
1 660
|
88
|
0
|
1 669
|
0
|
|
Total Liabilities |
23 245
N/A
|
26 927
+16%
|
26 912
0%
|
19 525
-27%
|
35 454
+82%
|
41 808
+18%
|
26 556
-36%
|
21 587
-19%
|
16 922
-22%
|
14 554
-14%
|
|
Equity | |||||||||||
Common Stock |
37 668
|
38 657
|
40 591
|
44 560
|
47 325
|
49 806
|
53 212
|
56 404
|
60 441
|
64 287
|
|
Retained Earnings |
78 525
|
82 461
|
86 711
|
94 429
|
98 194
|
96 113
|
101 897
|
101 387
|
102 786
|
101 503
|
|
Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Unrealized Security Profit/Loss |
204
|
8
|
193
|
173
|
351
|
650
|
550
|
534
|
519
|
0
|
|
Other Equity |
2 162
|
1 021
|
859
|
420
|
126
|
354
|
601
|
140
|
359
|
0
|
|
Total Equity |
118 558
N/A
|
122 131
+3%
|
128 354
+5%
|
139 582
+9%
|
145 294
+4%
|
144 916
0%
|
155 160
+7%
|
157 397
+1%
|
162 349
+3%
|
165 790
+2%
|
|
Total Liabilities & Equity |
141 803
N/A
|
149 058
+5%
|
155 266
+4%
|
159 107
+2%
|
180 748
+14%
|
186 724
+3%
|
181 715
-3%
|
178 984
-2%
|
179 271
+0%
|
180 344
+1%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
6 086
|
6 165
|
6 316
|
6 603
|
6 817
|
7 045
|
7 396
|
7 718
|
8 172
|
8 650
|